AVM Biotech
Deputy Director Livestrong Cancer Institutes, Professor Department of Oncology, Dell Medical School, received his AB in Biochemistry from Harvard and M.D. from the University of California SanFrancisco. Dr. Matsui has carried out research throughout his career making several key discoveries in clinical oncology.
This person is not in the org chart
This person is not in any offices
AVM Biotech
5 followers
AVM is a development-stage biotech company advancing the research, development and commercialization of game-changing stem cell technologies for high unmet medical needs in regenerative medicine, cancer treatment recovery, safer iPS cell culturing and treatment, and fully human biologics, including patient-specific biologics for personalized medicine (“Boutique Biologics™”) in orphan diseases.